Human Glioma Migration and Infiltration Properties as a Target for Personalized Radiation Medicine
- PMID: 30463322
- PMCID: PMC6266328
- DOI: 10.3390/cancers10110456
Human Glioma Migration and Infiltration Properties as a Target for Personalized Radiation Medicine
Abstract
Gliomas are primary brain tumors that present the majority of malignant adult brain tumors. Gliomas are subdivided into low- and high-grade tumors. Despite extensive research in recent years, the prognosis of malignant glioma patients remains poor. This is caused by naturally highly infiltrative capacities as well as high levels of radio- and chemoresistance. Additionally, it was shown that low linear energy transfer (LET) irradiation enhances migration and invasion of several glioma entities which might counteract today's treatment concepts. However, this finding is discussed controversially. In the era of personalized medicine, this controversial data might be attributed to the patient-specific heterogeneity that ultimately could be used for treatment. Thus, current developments in glioma therapy should be seen in the context of intrinsic and radiation-enhanced migration and invasion. Due to the natural heterogeneity of glioma cells and different radiation responses, a personalized radiation treatment concept is suggested and alternative radiation concepts are discussed.
Keywords: brain metastases; irradiation; migration and invasion; personalized medicine; primary brain tumor; radiotherapy; survival; treatment resistance; tumor heterogeneity.
Conflict of interest statement
The authors declare no conflict of interest.
Figures


Similar articles
-
Sublethal irradiation promotes migration and invasiveness of glioma cells: implications for radiotherapy of human glioblastoma.Cancer Res. 2001 Mar 15;61(6):2744-50. Cancer Res. 2001. PMID: 11289157
-
An in vitro and in vivo study of the role of long non-coding RNA-HOST2 in the proliferation, migration, and invasion of human glioma cells.IUBMB Life. 2019 Jan;71(1):93-104. doi: 10.1002/iub.1943. Epub 2018 Oct 5. IUBMB Life. 2019. PMID: 30290058
-
Low-grade gliomas -- current concepts.Zentralbl Neurochir. 2006 May;67(2):55-66. doi: 10.1055/s-2006-933408. Zentralbl Neurochir. 2006. PMID: 16673237 Review.
-
CXCR4 increases in-vivo glioma perivascular invasion, and reduces radiation induced apoptosis: A genetic knockdown study.Oncotarget. 2016 Dec 13;7(50):83701-83719. doi: 10.18632/oncotarget.13295. Oncotarget. 2016. PMID: 27863376 Free PMC article.
-
Input of molecular analysis in medical management of primary brain tumor patients.Rev Neurol (Paris). 2015 Jun-Jul;171(6-7):457-65. doi: 10.1016/j.neurol.2015.04.002. Epub 2015 May 27. Rev Neurol (Paris). 2015. PMID: 26026669 Review.
Cited by
-
Iron and copper complexes with antioxidant activity as inhibitors of the metastatic potential of glioma cells.RSC Adv. 2020 Mar 30;10(22):12699-12710. doi: 10.1039/d0ra00166j. eCollection 2020 Mar 30. RSC Adv. 2020. PMID: 35492123 Free PMC article.
-
Perampanel Add-on to Standard Radiochemotherapy in vivo Promotes Neuroprotection in a Rodent F98 Glioma Model.Front Neurosci. 2020 Nov 30;14:598266. doi: 10.3389/fnins.2020.598266. eCollection 2020. Front Neurosci. 2020. PMID: 33328869 Free PMC article.
-
Cancer-related circular RNA: diverse biological functions.Cancer Cell Int. 2021 Jan 6;21(1):11. doi: 10.1186/s12935-020-01703-z. Cancer Cell Int. 2021. PMID: 33407501 Free PMC article. Review.
-
Accelerated 3D whole-brain T1, T2, and proton density mapping: feasibility for clinical glioma MR imaging.Neuroradiology. 2021 Nov;63(11):1831-1851. doi: 10.1007/s00234-021-02703-0. Epub 2021 Apr 9. Neuroradiology. 2021. PMID: 33835238 Free PMC article.
-
Application of New Radiosensitizer Based on Nano-Biotechnology in the Treatment of Glioma.Front Oncol. 2021 Mar 22;11:633827. doi: 10.3389/fonc.2021.633827. eCollection 2021. Front Oncol. 2021. PMID: 33869019 Free PMC article. Review.
References
-
- Metha M.P., Buckner J.C., Sawaya R. DeVita, Hellman, and Rosenberg’s Cancer: Principles and Practice of Oncology. 8th ed. Wolters Kluwer/Lippincott Williams & Wilkins; Philadelphia, PA, USA: 2008. Neoplasms of the central nervous system.
-
- Louis D.N., Perry A., Reifenberger G., von Deimling A., Figarella-Branger D., Cavenee W.K., Ohgaki H., Wiestler O.D., Kleihues P., Ellison D.W. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: A summary. Acta Neuropathol. 2016;131:803–820. doi: 10.1007/s00401-016-1545-1. - DOI - PubMed
-
- McNeill K., Aldape K., Fine H.A. Molecular Pathology of Nervous System Tumors: Biological Stratification and Targeted Therapies. Springer; New York, NY, USA: 2015. Adult High-Grade (Diffuse) Glioma; pp. 77–93.
Publication types
LinkOut - more resources
Full Text Sources